These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30635292)

  • 81. [Pseudomonas aeruginosa colonisation in bronchiectatic patients and clinical reflections].
    Kömüs N; Tertemiz KC; Akkoçlu A; Gülay Z; Yilmaz E
    Tuberk Toraks; 2006; 54(4):355-62. PubMed ID: 17203422
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Acute respiratory failure due to gentamicin aerosolization.
    Melani AS; Di Gregorio A
    Monaldi Arch Chest Dis; 1998 Jun; 53(3):274-6. PubMed ID: 9785810
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis.
    Orriols R; Hernando R; Ferrer A; Terradas S; Montoro B
    Respiration; 2015; 90(4):299-305. PubMed ID: 26340658
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical impact of cardiovascular disease on patients with bronchiectasis.
    Chen S; Qiu A; Tao Z; Zhang H
    BMC Pulm Med; 2020 Apr; 20(1):101. PubMed ID: 32326931
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report.
    Jennes S; Merabishvili M; Soentjens P; Pang KW; Rose T; Keersebilck E; Soete O; François PM; Teodorescu S; Verween G; Verbeken G; De Vos D; Pirnay JP
    Crit Care; 2017 Jun; 21(1):129. PubMed ID: 28583189
    [No Abstract]   [Full Text] [Related]  

  • 86. In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates.
    Gupta S; Mittal S; Nayak N; Satpathy G; Khokhar S; Agarwal T
    Ocul Immunol Inflamm; 2015 Jun; 23(3):252-5. PubMed ID: 24564536
    [No Abstract]   [Full Text] [Related]  

  • 87. Respiratory infection in noncystic fibrosis bronchiectasis.
    Zoumot Z; Wilson R
    Curr Opin Infect Dis; 2010 Apr; 23(2):165-70. PubMed ID: 19996746
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Clinical effect of Kasugamycin on urinary tract infections due to Pseudomonas aeruginosa].
    Maekawa A
    J Antibiot B; 1967 Jun; 20(3):197-8. PubMed ID: 4965586
    [No Abstract]   [Full Text] [Related]  

  • 89. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
    Dhand R
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Carbenicillin in treatment of severe infections due to pseudomonas.
    Jordan MC; Standiford HC; Kirby WM
    J Infect Dis; 1970 Sep; 122():Suppl:S96+. PubMed ID: 4319045
    [No Abstract]   [Full Text] [Related]  

  • 91. Bronchiectasis-associated infections and outcomes in a large, geographically diverse electronic health record cohort in the United States.
    Dean SG; Blakney RA; Ricotta EE; Chalmers JD; Kadri SS; Olivier KN; Prevots DR
    BMC Pulm Med; 2024 Apr; 24(1):172. PubMed ID: 38600466
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Use of Plasmapheresis in Patients with Bronchiectasis with Pseudomonas aeruginosa Infection and Inhibitory Antibodies.
    Wells TJ; Davison J; Sheehan E; Kanagasundaram S; Spickett G; MacLennan CA; Stockley RA; Cunningham AF; Henderson IR; De Soyza A
    Am J Respir Crit Care Med; 2017 Apr; 195(7):955-958. PubMed ID: 28362198
    [No Abstract]   [Full Text] [Related]  

  • 93. Low Salivary Secretory Leukocyte Protease Inhibitor Levels Are Related to Airway Pseudomonas aeruginosa Infection in Bronchiectasis.
    Perea L; Faner R; Solarat B; Shoemark A; Aliberti S; Chalmers JD; Sibila O
    Chest; 2023 Aug; 164(2):323-326. PubMed ID: 36898430
    [No Abstract]   [Full Text] [Related]  

  • 94. Limited Validity of Diagnosis Code-based Claims to Identify
    Ku JH; Henkle EM; Aksamit TR; Winthrop KL
    Ann Am Thorac Soc; 2021 Jul; 18(7):1246-1249. PubMed ID: 33476243
    [No Abstract]   [Full Text] [Related]  

  • 95. Reducing
    Sibila O
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 33402373
    [No Abstract]   [Full Text] [Related]  

  • 96. Bronchiectasis and COVID-19: For Better or for Worse?
    Seo C; Kaur S; Thornton CS
    Ann Am Thorac Soc; 2024 Feb; 21(2):208-210. PubMed ID: 38299923
    [No Abstract]   [Full Text] [Related]  

  • 97. Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study.
    Duan JL; Li CY; Jiang Y; Liu C; Huang PR; Gao LF; Guan WJ; Cheng LL
    Respir Res; 2024 Jul; 25(1):283. PubMed ID: 39020401
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for
    Gao YH; Lu HW; Zheng HZ; Cao C; Chu DJ; Fan H; Fan XY; Gu HY; Guan WJ; Jie ZJ; Jin Y; Li W; Li YP; Li YY; Liu L; Liu XD; Luo H; Lv XD; Mo WQ; Song YL; Wang DX; Wang LW; Wang CZ; Xie M; Zhang M; Zheng CX; Mao B; Chotirmall SH; Chalmers JD; Qu JM; Xu JF
    ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38410702
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Eradication treatment for
    Conceição M; Shteinberg M; Goeminne P; Altenburg J; Chalmers JD
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38296344
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Precision medicine in bronchiectasis.
    Pembridge T; Chalmers JD
    Breathe (Sheff); 2021 Dec; 17(4):210119. PubMed ID: 35035573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.